| Crystal structure of human TLR8 in complex with CU-CPD107 | | homo-2-mer | 32-827 | 100.0 | 1×NAG; 1×NAG; 1×NAG; 2×NAG; 1×NAG; 2×GD0; 21×NAG; |
|
| Discovery of M5049: a novel selective TLR7/8 inhibitor for treatment of autoimmunity | | homo-2-mer | 30-822 | 100.0 | 2×NAG; 2×NAG; 2×NAG; 9×NAG; 2×QLH; 1×FMT; |
|
| Crystal structure of TLR8 in complex with its antagonist | | homo-2-mer | 32-821 | 100.0 | 1×NAG; 2×NAG; 2×NAG; 1×NAG; 2×JRI; 18×NAG; |
|
| Crystal structure of human TLR8 in complex with XG-1-236 | | homo-2-mer | 31-819 | 100.0 | 3×NAG; 1×NAG; 5×NAG; 2×XG1; |
|
| Crystal structure of human TLR8 in complex with DS-802 | | homo-2-mer | 31-818 | 100.0 | 1×NAG; 2×NAG; 2×NAG; 1×NAG; 11×NAG; 2×D80; |
|
| Crystal structure of human TLR8 in complex with N1-4-aminomethylbenzyl (IMDQ) | | homo-2-mer | 31-818 | 100.0 | 2×NAG; 2×NAG; 2×NAG; 2×IDQ; 14×NAG; |
|
| Crystal structure of human TLR8 in complex with Hybrid-2 | | homo-2-mer | 31-818 | 100.0 | 2×NAG; 4×NAG; 10×NAG; 2×HB2; |
|
| Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 3 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 13×NAG; 2×RX8; 1×GOL; |
|
| Crystal structure of human TLR8 (unliganded form) | | homo-2-mer | 32-819 | 100.0 | 5×NAG; 1×NAG; 10×NAG; 1×BU3; |
|
| Crystal structure of human TLR8 in complex with CL075 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 1×NAG; 1×NAG; 2×L07; 6×NAG; |
|
| Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 1 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 8×NAG; 4×SO4; 2×RX8; |
|
| Crystal structure of human TLR8 in complex with CU-CPT8m | | homo-2-mer | 32-819 | 100.0 | 3×NAG; 2×NAG; 1×NAG; 6×NAG; 2×CU8; |
|
| Crystal structure of human TLR8 in complex with MB-343 | | homo-2-mer | 31-818 | 100.0 | 3×NAG; 2×NAG; 1×NAG; 2×MBL; 7×NAG; |
|
| Human TLR8 bound to the potent agonist, GS-9688 (Selgantolimod) | | homo-2-mer | 31-818 | 100.0 | 1×NAG; 1×NAG; 4×NAG; 6×MAN; 9×NAG; 2×U57; |
|
| Crystal structure of human TLR8 in complex with MB-564 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 5×NAG; 2×M4D; |
|
| Crystal structure of human TLR8 in complex with ORN06S | | homo-2-mer | 32-819 | 100.0 | 1×NAG; 4×NAG; 1×NAG; 2×URI; 2×06S; 2×UPT; 2×NAG; |
|
| Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 2 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 2×RX8; 8×NAG; 2×SO4; |
|
| Crystal structure of human TLR8 in complex with compound 34 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 12×NAG; 2×YHG; |
|
| Crystal structure of human TLR8 in complex with Compound 4 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 12×NAG; 2×I5B; |
|
| Crystal structure of human TLR8 in complex with Compound 2 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 12×NAG; 2×I6A; |
|
| Crystal structure of human TLR8 in complex with Compound 15 | | homo-2-mer | 31-818 | 100.0 | 4×NAG; 2×NAG; 12×NAG; 2×I5N; |
|
| Crystal structure of human TLR8 in complex with DS-877 | | homo-2-mer | 32-818 | 100.0 | 2×NAG; 4×NAG; 2×D87; 18×NAG; |
|
| Crystal structure of human TLR8 in complex with ORN06 | | homo-2-mer | 32-818 | 100.0 | 1×NAG; 3×NAG; 2×NAG; 2×URI; 2×UCG; 10×NAG; |
|
| Crystal structure of human TLR8 in complex with CL097 | | homo-2-mer | 31-817 | 100.0 | 2×NAG; 2×NAG; 2×NAG; 8×NAG; 2×C09; 16×SO4; 1×GOL; |
|
| Crystal structure of human TLR8 in complex with N1-3-aminomethylbenzyl (meta-amine) | | homo-2-mer | 31-817 | 100.0 | 2×NAG; 2×NAG; 2×NAG; 2×M0A; 6×NAG; |
|
| Crystal structure of human TLR8 in complex with CU-CPT9b | | homo-2-mer | 32-818 | 100.0 | 3×NAG; 2×NAG; 1×NAG; 2×7VF; 4×NAG; |
|
| Crystal structure of human TLR8 in complex with ssRNA40 | | homo-2-mer | 32-818 | 100.0 | 4×NAG; 2×NAG; 2×URI; 10×NAG; 2×UCG; |
|
| Crystal structure of human TLR8 ectodomain bound to small molecule antagonist 14c | | homo-2-mer | 32-818 | 100.0 | 4×NAG; 1×NAG; 1×NAG; 17×NAG; 2×QSM; |
|
| Crystal structure of human TLR8 ectodomain bound to small molecule antagonist 21 | | homo-2-mer | 32-818 | 100.0 | 2×NAG; 3×NAG; 1×NAG; 14×NAG; 2×RQY; |
|
| Crystal structure of human TLR8 in complex with CU-CPT9a | | homo-2-mer | 32-818 | 100.0 | 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 2×7VC; 3×NAG; |
|
| Crystal structure of human TLR8 in complex TH1027 | | homo-2-mer | 32-818 | 100.0 | 2×NAG; 2×NAG; 2×NAG; 2×DY3; 8×NAG; |
|
| Crystal structure of human TLR8 in complex with CU-CPT9c | | homo-2-mer | 32-818 | 100.0 | 3×NAG; 2×NAG; 1×NAG; 2×7VL; 1×MAN; 4×NAG; |
|
| Crystal structure of human TLR8 in complex with uridine mononucleoside | | homo-2-mer | 32-817 | 100.0 | 2×NAG; 2×NAG; 2×NAG; 2×URI; 14×NAG; |
|
| Crystal structure of human TLR8 in complex with MB-568 | | homo-2-mer | 32-816 | 100.0 | 2×NAG; 2×NAG; 2×NAG; 2×M8D; 12×NAG; |
|
| Crystal structure of human TLR8 with an uncleaved Z-loop | | monomer | 33-823 | 100.0 | 1×NAG; 1×NAG; 1×NAG; 6×NAG; 3×SO4; 1×MES; |
|
| Crystal structure of human TLR8 in complex with Compound 11 | | monomer | 31-818 | 100.0 | 2×NAG; 1×NAG; 6×NAG; |
|